CDER approved 37 novel drugs in 2022, its lowest number since 2016
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsProduct Lifecycle